JP2007523166A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2007523166A5 JP2007523166A5 JP2006554129A JP2006554129A JP2007523166A5 JP 2007523166 A5 JP2007523166 A5 JP 2007523166A5 JP 2006554129 A JP2006554129 A JP 2006554129A JP 2006554129 A JP2006554129 A JP 2006554129A JP 2007523166 A5 JP2007523166 A5 JP 2007523166A5
- Authority
- JP
- Japan
- Prior art keywords
- contain
- substituted
- branched
- combination
- heteroatoms
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 125000005842 heteroatom Chemical group 0.000 claims 60
- 125000003118 aryl group Chemical group 0.000 claims 18
- 125000000753 cycloalkyl group Chemical group 0.000 claims 18
- 101001035752 Homo sapiens Hydroxycarboxylic acid receptor 3 Proteins 0.000 claims 13
- 102100039356 Hydroxycarboxylic acid receptor 3 Human genes 0.000 claims 13
- 125000003342 alkenyl group Chemical group 0.000 claims 12
- 125000000217 alkyl group Chemical group 0.000 claims 12
- 125000000304 alkynyl group Chemical group 0.000 claims 12
- 239000000556 agonist Substances 0.000 claims 7
- 125000001072 heteroaryl group Chemical group 0.000 claims 6
- 125000000623 heterocyclic group Chemical group 0.000 claims 6
- 229910052739 hydrogen Inorganic materials 0.000 claims 6
- 239000001257 hydrogen Substances 0.000 claims 6
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 6
- 229940125425 inverse agonist Drugs 0.000 claims 5
- 239000005557 antagonist Substances 0.000 claims 4
- 230000007781 signaling event Effects 0.000 claims 4
- 230000000694 effects Effects 0.000 claims 3
- 150000001875 compounds Chemical class 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- 206010061218 Inflammation Diseases 0.000 claims 1
- 230000004054 inflammatory process Effects 0.000 claims 1
- 230000001105 regulatory effect Effects 0.000 claims 1
- 230000011664 signaling Effects 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US54601104P | 2004-02-20 | 2004-02-20 | |
| PCT/US2005/004108 WO2005082350A1 (en) | 2004-02-20 | 2005-02-10 | Furosemide derivatives as modulators of hm74 and their use for the treatment of inflammation |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2007523166A JP2007523166A (ja) | 2007-08-16 |
| JP2007523166A5 true JP2007523166A5 (enExample) | 2008-01-17 |
Family
ID=34910746
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006554129A Pending JP2007523166A (ja) | 2004-02-20 | 2005-02-10 | Ｈｍ７４の調節剤としてのフロセミド誘導体および炎症を処置するためのそれらの使用 |
Country Status (24)
| Country | Link |
|---|---|
| US (2) | US7232811B2 (enExample) |
| EP (1) | EP1718292A1 (enExample) |
| JP (1) | JP2007523166A (enExample) |
| KR (1) | KR20060127141A (enExample) |
| CN (1) | CN1921845A (enExample) |
| AR (1) | AR047747A1 (enExample) |
| AU (1) | AU2005216879B2 (enExample) |
| BR (1) | BRPI0506792A (enExample) |
| CA (1) | CA2557444A1 (enExample) |
| CR (1) | CR8528A (enExample) |
| EC (1) | ECSP066777A (enExample) |
| IL (1) | IL177086A (enExample) |
| MA (1) | MA28373A1 (enExample) |
| ME (1) | MEP21108A (enExample) |
| MX (1) | MXPA06008612A (enExample) |
| NO (1) | NO20064237L (enExample) |
| NZ (1) | NZ548830A (enExample) |
| RS (1) | RS20060473A (enExample) |
| RU (1) | RU2006133540A (enExample) |
| SG (1) | SG164305A1 (enExample) |
| TN (1) | TNSN06234A1 (enExample) |
| TW (1) | TW200538109A (enExample) |
| WO (1) | WO2005082350A1 (enExample) |
| ZA (1) | ZA200606679B (enExample) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8008283B2 (en) | 1998-12-23 | 2011-08-30 | Neurotherapeutics Pharma, Inc. | Methods and compositions for the treatment of neuropsychiatric disorders |
| US7094572B2 (en) | 2003-03-14 | 2006-08-22 | Bristol-Myers Squibb | Polynucleotide encoding a novel human G-protein coupled receptor variant of HM74, HGPRBMY74 |
| WO2006060461A1 (en) | 2004-12-03 | 2006-06-08 | Schering Corporation | Substituted piperazines as cb1 antagonists |
| EP1968603A4 (en) * | 2006-01-03 | 2013-01-16 | Algebra Inc | THERAPEUTIC AMINARYLSULFONAMIDE CONJUGATE COMPOUNDS |
| BRPI0706623A2 (pt) * | 2006-01-18 | 2011-04-12 | Schering Corp | moduladores de receptor canabinóide |
| US7906555B2 (en) | 2006-10-26 | 2011-03-15 | Arizona Board Of Regents On Behalf Of The University Of Arizona | Aquaporin modulators and methods of using them for the treatment of edema and fluid imbalance |
| US20100197564A1 (en) * | 2007-04-19 | 2010-08-05 | Schering Corporation | Diaryl morpholines as cb1 modulators |
| US20100286160A1 (en) * | 2007-06-28 | 2010-11-11 | Intervet Inc. | Substituted piperazines as cb1 antagonists |
| EP2548874A3 (en) * | 2007-06-28 | 2013-05-15 | Intervet International B.V. | Substituted piperazines as CB1 antagonists |
| LT6401B (lt) * | 2015-07-28 | 2017-06-12 | Vilniaus Universitetas | Karboanhidrazės selektyvūs inhibitoriai |
Family Cites Families (16)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3875150A (en) | 1969-04-29 | 1975-04-01 | Leo Pharm Prod Ltd | New sulfamyl-anthranilic acids |
| GB1260155A (en) * | 1969-04-29 | 1972-01-12 | Leo Pharm Prod Ltd | Sulphonamido anthranilic acid derivatives |
| AT324318B (de) * | 1971-02-15 | 1975-08-25 | Dumex Ltd As | Verfahren zur herstellung von furanderivaten |
| DE2247828A1 (de) * | 1972-09-29 | 1974-04-04 | Hoechst Ag | Sulfamoyl-anthranilsaeuren und verfahren zu ihrer herstellung |
| DE2406972C3 (de) * | 1974-02-14 | 1979-07-19 | Hoechst Ag, 6000 Frankfurt | Verfahren zur Herstellung von 5-Sulfamoylanthranilsäuren |
| DE2718871C3 (de) * | 1977-04-28 | 1980-07-17 | Hoechst Ag, 6000 Frankfurt | N-(2-Furylmethyl)-5-sulfamoylorthanilsäuren und deren physiologisch verträgliche Salze und Verfahren zu ihrer Herstellung und ihre Verwendung bei der Bekämpfung von Oedemkrankheiten und Bluthochdruck |
| US4406896A (en) * | 1979-12-20 | 1983-09-27 | Merck & Co., Inc. | Adjuvants for rectal delivery of drug substances |
| DE3006686A1 (de) * | 1980-02-22 | 1981-08-27 | Hoechst Ag, 6000 Frankfurt | 5-sulfamoyl-orthanilsaeuren, verfahren zu ihrer herstellung und ihre verwendung als heilmittel |
| DE3041812A1 (de) * | 1980-11-06 | 1982-06-16 | Hoechst Ag, 6000 Frankfurt | Basisch substituierte 5-phenyltetrazole, verfahren zu ihrer herstellung und ihre verwendung als heilmittel |
| DE3101960A1 (de) * | 1981-01-22 | 1982-09-02 | Hoechst Ag, 6000 Frankfurt | "basisch substituierte anthranilsaeuren, verfahren zu ihrer herstellung und ihre verwendung" |
| US5256687A (en) * | 1985-09-09 | 1993-10-26 | Hoechst Aktiengesellschaft | Pharmaceutical composition for the treatment of high blood pressure |
| JPH0720862B2 (ja) * | 1989-01-27 | 1995-03-08 | ヘキスト・アクチエンゲゼルシヤフト | 吸入用喘息治療剤 |
| JP2002508660A (ja) * | 1997-06-12 | 2002-03-19 | スミスクライン ビーチャム コーポレーション | Ｈｍ７４ａ受容体 |
| GB0021484D0 (en) * | 2000-09-01 | 2000-10-18 | Boehringer Ingelheim Pharma | Method for identifying substances which positively influence inflammatory conditions of chronic inflammatory airway diseases |
| DE10060809A1 (de) * | 2000-12-07 | 2002-06-20 | Aventis Pharma Gmbh | Substituierte Anthranilsäuren, ihre Verwendung als Medikament oder Diagnostikum, sowie sie enthaltendes Medikament, sowie ein pharmazeutisches Kombinationspräparat mit einem Natrium/Wasserstoff-Austausch (NHE)-Blocker |
| US20030109673A1 (en) * | 2002-10-04 | 2003-06-12 | Xiao Yonghong | Regulation of human hm74-like g protein coupled receptor |
-
2005
- 2005-02-10 KR KR1020067016657A patent/KR20060127141A/ko not_active Withdrawn
- 2005-02-10 JP JP2006554129A patent/JP2007523166A/ja active Pending
- 2005-02-10 CN CNA2005800054570A patent/CN1921845A/zh active Pending
- 2005-02-10 MX MXPA06008612A patent/MXPA06008612A/es active IP Right Grant
- 2005-02-10 CA CA002557444A patent/CA2557444A1/en not_active Abandoned
- 2005-02-10 RU RU2006133540/04A patent/RU2006133540A/ru not_active Application Discontinuation
- 2005-02-10 WO PCT/US2005/004108 patent/WO2005082350A1/en not_active Ceased
- 2005-02-10 NZ NZ548830A patent/NZ548830A/en unknown
- 2005-02-10 EP EP05713210A patent/EP1718292A1/en not_active Withdrawn
- 2005-02-10 AU AU2005216879A patent/AU2005216879B2/en not_active Ceased
- 2005-02-10 RS RSP-2006/0473A patent/RS20060473A/sr unknown
- 2005-02-10 SG SG200901539-7A patent/SG164305A1/en unknown
- 2005-02-10 BR BRPI0506792-8A patent/BRPI0506792A/pt not_active IP Right Cessation
- 2005-02-10 ME MEP-211/08A patent/MEP21108A/xx unknown
- 2005-02-14 US US11/057,587 patent/US7232811B2/en not_active Expired - Fee Related
- 2005-02-18 TW TW094104731A patent/TW200538109A/zh unknown
- 2005-02-18 AR ARP050100596A patent/AR047747A1/es not_active Application Discontinuation
-
2006
- 2006-07-24 CR CR8528A patent/CR8528A/es not_active Application Discontinuation
- 2006-07-25 IL IL177086A patent/IL177086A/en not_active IP Right Cessation
- 2006-07-28 TN TNP2006000234A patent/TNSN06234A1/en unknown
- 2006-08-11 ZA ZA200606679A patent/ZA200606679B/xx unknown
- 2006-08-18 EC EC2006006777A patent/ECSP066777A/es unknown
- 2006-08-29 MA MA29295A patent/MA28373A1/fr unknown
- 2006-09-19 NO NO20064237A patent/NO20064237L/no not_active Application Discontinuation
-
2007
- 2007-05-07 US US11/745,131 patent/US7556931B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CL2008003529A1 (es) | Compuestos derivados de acido-[(4,5-disustituido)-4h-1,2,4-triazol-3-il o (2,4-disustituido)-1,3-imidazol-2-il]carboxilico, moduladores de los niveles de acido urico sanguineos, utiles para el tratamiento de la gota. | |
| PE20060361A1 (es) | Compuestos heterociclicos como inhibidores de la cinesina mitotica | |
| EA201390877A1 (ru) | Замещенные 6,6-конденсированные азотсодержащие гетероциклические соединения и их применение | |
| FR2838439B1 (fr) | Derives de terphenyle, leur preparation, les compositions pharmaceutqiues en contenant | |
| NO20090910L (no) | Sulfonamid-derivater som adrenerge agonister og muskariniske antagonister | |
| ATE554085T1 (de) | Neue inhibitoren von glutaminylcyclase | |
| NO20051165L (no) | Benzotiazolderivater som har -adrenoerseptorantagonist aktivitet | |
| JP2010504286A5 (enExample) | ||
| DE602004012858D1 (de) | 2-aminobenzothiazole als cb1 rezeptor inverse agonisten | |
| PE20090709A1 (es) | Compuestos heterociclico de 5 miembros | |
| EA201390916A1 (ru) | Новые ферроценовые метки для электрохимического анализа и их применение в аналитических способах | |
| DE60215028D1 (de) | Indol derivate als beta-3-adrenerge agonisten zur behandlung von typ 2 diabetes | |
| RU2007125726A (ru) | Новое производное антраниловой кислоты или его соль | |
| PE20080843A1 (es) | Inhibidores de renina y metodo para su utilizacion | |
| JP2020504754A5 (enExample) | ||
| RU2011102396A (ru) | Аминосоединения и их медицинское применение | |
| NO20063621L (no) | Derivater av N-`(1,5-difenyl-1H-pyrazol-3-yl) sulfonamid med CB1 receptoraffinitet | |
| ATE479699T1 (de) | Neue markierungsstrategien für den empfindlichen nachweis von analyten | |
| AR076362A1 (es) | Arilsulfonamidas 2,5-disustituidas antagonistas de ccr3, composiciones farmaceuticas que las contienen y uso de las mismas para el tratamiento y/o prevencion de patologias autoinmunes e inflamatorias, entre otras. | |
| PE20040929A1 (es) | Amidas de acido 5-aminometil-1h-pirrol-2-carboxilico substituidas | |
| PE20060770A1 (es) | Derivados de n-[(4,5-difenil-3-alquil-2-tienil)metil]amina como antagonistas de los receptores cannabinoides cb1 | |
| RU2006113941A (ru) | Лечение невропатической боли агонистами рецептора 2 нейропептида ff | |
| RU2006133540A (ru) | Фуросемидные модуляторы нм74 | |
| EA200702612A1 (ru) | Соединения бензимидазолкарбоксамида в качестве агонистов рецепторов 5-нт | |
| FI20031454A0 (fi) | Selektiivisiä somatostatiinireseptori 1 ja/tai 4 -agonisteja ja -antagonisteja |